XPECT EYEWASH- eyewash solution 
Cintas Corporation

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Xpect Eyewash

Active ingredient

Purified water 98.4%

Purpose

Eyewash

Use For cleansing the eye to help relieve irritation by removing loose foreign material, air pollutants, or chlorinated water. 

Warnings

For external use only

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away

Directions

Other information

Inactive ingredients boric acid, sodium borate, sodium chloride, sorbic acid

Questions?Call 1-877-973-2811 M-F 8 am-5 pm

Principal Display Panel - 118mL Bottle

EYEWASH

Purified water 98.4%

Sterile

Single use only

For flushing the eye to help relieve irritation, burning, or itching by removing loose foreign material or air pollutants (smog or pollen).

CAUTION: Tamper-evident cap. Do not use if twist-off top is broken or missing. 

4 fl. oz. (118 mL)

Xpect® First aid

118mLBottle

Principal Display Panel - 4 Count Box

EYEWASH

Purified water 98.4%

Sterile

Single use only

For flushing the eye to help relieve irritation, burning, or itching by removing loose foreign material or air pollutants (smog or pollen). 

Xpect® First aid

Distributed by: Cintas® • Mason, OH 45040 • www.cintas.com

NET WT PER BTL 1/2 OZ

4 Bottles per Box

130479

4CT_BOX

XPECT EYEWASH 
eyewash solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:42961-231
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
WATER (UNII: 059QF0KO0R) (WATER - UNII:059QF0KO0R) WATER.984 mL  in 1 mL
Inactive Ingredients
Ingredient NameStrength
BORIC ACID (UNII: R57ZHV85D4)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SORBIC ACID (UNII: X045WJ989B)  
SODIUM BORATE (UNII: 91MBZ8H3QO)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:42961-231-03118 mL in 1 BOTTLE; Type 0: Not a Combination Product07/11/2023
2NDC:42961-231-024 in 1 BOX07/11/2023
2NDC:42961-231-0115 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34907/11/2023
Labeler - Cintas Corporation (056481716)
Establishment
NameAddressID/FEIBusiness Operations
Amsino Healthcare Inc.116914622manufacture(42961-231)

Revised: 7/2023
Document Id: 7e94db94-278c-4e9c-b01e-65af3eaef915
Set id: 1d69365d-662b-4248-8fa9-1629451b549a
Version: 2
Effective Time: 20230711
 
Cintas Corporation